文献速递创伤骨科骨质疏松与代谢性骨病

Charlson与Elixhauser评分在髋部骨折术后1年死亡风险评估中优于ASA评分

The Charlson and Elixhauser Scores Outperform the American Society of Anesthesiologists Score in Assessing 1-year Mortality Risk After Hip Fracture Surgery.
PubMed 文献 · Clin Orthop Relat Res · 2021-01-01

本研究回顾性分析2016年10月至2019年5月两家一级创伤中心和三家社区医院共1456例髋部骨折手术患者,比较ASA、CCI和ECI对90天和1年死亡的预测准确性。结果显示,CCI和ECI对1年死亡的预测准确性均优于ASA,且两者无差异;ECI对90天死亡的预测优于ASA。

要点

  • CCI和ECI对髋部骨折术后1年死亡的预测准确性优于ASA评分。
  • ECI对90天死亡的预测准确性优于ASA,而CCI与ASA无差异。
  • CCI与ECI在预测1年死亡方面准确性相当,无统计学差异。

核心结论

  • 在髋部骨折手术后,CCI和ECI对1年死亡的预测准确性均优于ASA评分,且两者之间无差异。
  • ECI对90天死亡的预测准确性优于ASA评分,而CCI与ASA无差异。

研究设计与样本

  • 回顾性研究,纳入2016年10月至2019年5月两家一级创伤中心和三家社区医院所有初次髋部骨折手术患者,最终分析1456例。
  • 排除病理骨折38例、假体周围骨折12例和年龄小于18岁10例;69%为女性,平均年龄77±14岁。

主要发现

  • 1年死亡率为15.0%,90天死亡率为7.4%。
  • 1年死亡的AUC:ASA 0.685(95%CI 0.656-0.714),ECI 0.755(95%CI 0.722-0.788),CCI 0.769(95%CI 0.739-0.800)。
  • CCI和ECI对1年死亡的预测准确性均优于ASA(p < 0.001),CCI与ECI无差异(p = 0.30)。
  • 90天死亡的AUC:ECI 0.756(95%CI 0.712-0.800)优于ASA 0.703(95%CI 0.663-0.744)(p = 0.04)。
  • 90天死亡CCI(AUC 0.742,95%CI 0.698-0.785)与ASA(p = 0.17)及CCI与ECI(p = 0.46)均无差异。

关键数值与推荐

  • ASA平均分2.8±0.6,CCI平均分3.1±3.2,ECI平均分5.2±3.5。
  • 手术方式:髓内钉45%(656/1456),半髋置换32%(464/1456),全髋置换10%(149/1456),经皮固定7%(104/1456),钢板螺钉6%(83/1456)。

临床怎么用

  • CCI或ECI可作为髋部骨折患者术前评估1年死亡风险的有用指标。
  • 涉及90天及以上结局的机构骨科研究宜采用CCI或ECI进行风险调整。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Risk adjustment has implications across orthopaedics, including informing clinical care, improving payment models, and enabling observational orthopaedic research. Although comorbidity indices (such as the American Society of Anesthesiologists [ASA] classification, Charlson comorbidity index [CCI], and Elixhauser comorbidity index [ECI]) have been examined extensively in the immediate perioperative period, there is a dearth of data on their three-way comparative effectiveness and long-term performance. Moreover, the discriminative ability of the CCI and ECI after orthopaedic surgery has not been validated in the ICD-10 era, despite new diagnosis codes from which they are calculated. QUESTION/PURPOSE: Which comorbidity index (ASA, CCI, or ECI) is associated with the greatest accuracy on receiver operating curve (ROC) analysis with respect to the endpoint of death at 90 days and 1 year after hip fracture surgery in the ICD-10 era? METHODS: A retrospective study was conducted on all patients undergoing surgical fixation of primary hip fractures at two Level I trauma centers and three community hospitals from October 2016 to May 2019. This time frame allowed for a 1-year baseline period of ICD-10 data to assess comorbidities and at least a 1-year follow-up period to assess mortality. Initially 1516 patients were identified using Common Procedural Terminology and ICD codes, of whom 4% (60 of 1516) were excluded after manual review; namely, those with pathologic fractures (n = 38), periprosthetic fractures (n = 12), and age younger than 18 years (n = 10). Of the patients who were studied, 69% (998 of 1456) were women and the mean ± SD age was 77 ± 14 years; 45% (656 of 1456) were treated with intramedullary nails, 32% (464 of 1456) underwent hemiarthroplasties, 10% (149 of 1456) underwent THAs, 7% (104 of 1456) underwent percutaneous fixations, and 6% (83 of 1456) were treated with plates and screws. The mean ± SD ASA score was 2.8 ± 0.6, CCI was 3.1 ± 3.2, and ECI was 5.2 ± 3.5. Hip fracture fixation was chosen as the operation of interest given the high incidence of this injury, the well-documented effects of comorbidities on complications, and the critical importance of risk stratification and perioperative medical management for these patients. Demographics, comorbidities, surgical details, as well as 90-day and 1-year mortality were collected. Logistic regressions with ROC curves were used to determine the accuracy and comparative effectiveness of the three measures. The 90-day mortality rate was 7.4%, and the 1-year mortality rate was 15.0%. RESULTS: The accuracy (area under the curve [AUC]) for 1-year mortality was 0.685 (95% CI 0.656 to 0.714) for the ASA, 0.755 (95% CI 0.722 to 0.788) for the ECI, and 0.769 (95% CI 0.739 to 0.800) for the CCI. The CCI and ECI were more accurate than ASA (p < 0.001 for both), while the CCI and ECI did not differ (p = 0.30). The ECI (AUC 0.756 [95% CI 0.712 to 0.800]) was more accurate for 90-day mortality than the ASA (AUC 0.703 [95% CI 0.663 to 0.744]; p = 0.04), while CCI (AUC 0.742 [95% CI 0.698 to 0.785]) with ASA (p = 0.17) and CCI with ECI (p = 0.46) did not differ at 90 days. CONCLUSION: Performance measures and research results may vary depending on what comorbidity index is used. We found that the CCI and ECI were more accurate than the ASA score for 1-year mortality after hip fracture surgery. Moreover, these data validate that the CCI and ECI can perform reliably in the ICD-10 era. If other studies from additional practice settings confirm these findings, as would be expected because of the objective nature of these indices, the CCI or ECI may be a useful preoperative measure for surgeons to assess 1-year mortality for hip fracture patients and should likely be used for institutional orthopaedic research involving outcomes 90 days and beyond. LEVEL OF EVIDENCE: Level III, diagnostic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Varady NH, Gillinov SM, Yeung CM, et al. The Charlson and Elixhauser Scores Outperform the American Society of Anesthesiologists Score in Assessing 1-year Mortality Risk After Hip Fracture Surgery. Clin Orthop Relat Res. 2021. PMID: 33930000. doi:10.1097/CORR.0000000000001772

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。